• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.44 Down 0.03(0.67%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 36,970   81,394   27,587  
    Cost of Revenue7,759  6,180  3,671  
    Gross Profit 29,211   75,214   23,916  
    Operating Expenses
    Research Development100,347  66,468  54,112  
    Selling General and Administrative34,137  31,681  26,226  
    Non Recurring -   -   -  
    Others -   -  691  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (105,273) (22,935) (57,113)
    Income from Continuing Operations
    Total Other Income/Expenses Net51,680  10,591  (19,244)
    Earnings Before Interest And Taxes(53,593)(12,344)(70,019)
    Interest Expense6,915  7,091  9,120  
    Income Before Tax(60,508)(19,435)(79,139)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(60,508)(19,435)(85,477)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (60,508) (19,435) (85,477)
    Preferred Stock And Other Adjustments -   -  (2,824)
    Net Income Applicable To Common Shares (60,508) (19,435) (88,301)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.